Mannitol inhalation diagnostic/theranostic - Pharmaxis

Drug Profile

Mannitol inhalation diagnostic/theranostic - Pharmaxis

Alternative Names: Aridol; Osmohale

Latest Information Update: 19 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmaxis
  • Developer Allertec Hellas; Nigaard Pharma; Pharmaxis; Praxis Pharmaceuticals; Trimedal
  • Class Small molecules; Sugar alcohols
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma
  • No development reported Chronic obstructive pulmonary disease

Most Recent Events

  • 20 Jul 2015 Nigaard Pharma has been acquired by Zambon SpA
  • 23 Feb 2011 Launched for Asthma in USA (Inhalation)
  • 06 Oct 2010 Registered for Asthma in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top